Rociclovir

MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus. MERS-CoV-IN-1 is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS) (extracted from patent WO2018174442A1, compound

Oligosaccharyltransferase (OST) inhibitor: anti-flaviviral.

Omaciclovir (H2G) is a potent and selective inhibitor of herpesvirus replication. Omaciclovir is a nucleoside analog with antiviral activity.In VitroOmaciclovir is a nucleoside analog with in vitro inhibitory activity against varicella-zoster virus

Omaciclovir (H2G) is a potent and selective inhibitor of herpesvirus replication. Omaciclovir is a nucleoside analog with antiviral activity.In VitroOmaciclovir is a nucleoside analog with in vitro inhibitory activity against varicella-zoster virus

Omaciclovir (H2G) is a potent and selective inhibitor of herpesvirus replication. Omaciclovir is a nucleoside analog with antiviral activity.In VitroOmaciclovir is a nucleoside analog with in vitro inhibitory activity against varicella-zoster virus

Omaciclovir (H2G) is a potent and selective inhibitor of herpesvirus replication. Omaciclovir is a nucleoside analog with antiviral activity.In VitroOmaciclovir is a nucleoside analog with in vitro inhibitory activity against varicella-zoster virus

Pirodavir (R 77975) is the prototype of a novel class of broad-spectrum antipicornavirus compounds: potent human rhinovirus (HRV) capsid-binding inhibitor.

Pirodavir (R 77975) is the prototype of a novel class of broad-spectrum antipicornavirus compounds: potent human rhinovirus (HRV) capsid-binding inhibitor.

Pirodavir (R 77975) is the prototype of a novel class of broad-spectrum antipicornavirus compounds: potent human rhinovirus (HRV) capsid-binding inhibitor.

Product Features: Exceptional value for money Rapid detection of all clinically relevant subtypes Positive copy number standard curve for quantification Highly specific detection profile High priming efficiency Broad dynamic detection range (&gt6 lo

SARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases.Form:Solid.

SARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases.Form:Solid.